pentosidine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iguchi, Y; Kitagawa, T; Komatsu, T; Mitsumura, H; Murakami, H; Omoto, S; Saito, M; Sakai, K; Sato, T; Shiraishi, T; Takatsu, H; Umehara, T | 1 |
| Castellani, R; Perry, G; Richey, PL; Smith, MA | 1 |
2 other study(ies) available for pentosidine and Parkinson Disease
| Article | Year |
|---|---|
The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson's disease.
Topics: Arginine; Cognition; Humans; Lysine; Parkinson Disease | 2022 |
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
Topics: Aged; Aged, 80 and over; Arginine; Cerebral Cortex; Cross-Linking Reagents; Glycation End Products, Advanced; Glycosylation; Heme Oxygenase (Decyclizing); Humans; Immunohistochemistry; Locus Coeruleus; Lysine; Microscopy, Immunoelectron; Middle Aged; Neurons; Norleucine; Oxidative Stress; Parkinson Disease; Pyrroles; Substantia Nigra | 1996 |